Interactions médicamenteuses
Baricitinib + Tisagenlecleucel
Gravité: Majeure
Baricitinib and Tisagenlecleucel: major interaction.
Dernière mise à jour
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
Résumé
Baricitinib may impair CAR T-cell expansion and activity, possibly reducing efficacy. It also adds to the infection risk that follows lymphodepletion and CAR T therapy.
Ce que signifie cette interaction, en termes simples
Baricitinib and Tisagenlecleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Baricitinib belongs to Musculoskeletal; Tisagenlecleucel belongs to Oncology.
Pourquoi elle survient
JAK inhibition suppresses T-cell activation and cytokine signaling, adding to immunosuppression and potentially limiting CAR T activity.
Conduite à tenir
Avoid baricitinib around leukapheresis and CAR T infusion unless clearly needed. Coordinate with the oncology team and monitor for infection.
Questions à poser à votre pharmacien
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Baricitinib et Tisagenlecleucel, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Essayez Pro+ gratuitement pendant 7 jours sur le web. Sans carte.
Autres interactions de Baricitinib
- Adenovirus types 4 and 7 live + Baricitinib Contre-indiquée
- Baricitinib + Bcg vaccine live Contre-indiquée
- Baricitinib + Tofacitinib Contre-indiquée
- Baricitinib + Upadacitinib Contre-indiquée
- Abatacept + Baricitinib Majeure
- Adalimumab + Baricitinib Majeure
Autres interactions de Tisagenlecleucel
- Measles mumps and rubella vaccine + Tisagenlecleucel Contre-indiquée
- Abatacept + Tisagenlecleucel Majeure
- Adalimumab + Tisagenlecleucel Majeure
- Anti-thymocyte + Tisagenlecleucel Majeure
- Azathioprine + Tisagenlecleucel Majeure
- Basiliximab + Tisagenlecleucel Majeure
Questions fréquentes
Can I take Baricitinib with Tisagenlecleucel?
MediHelp rates the interaction as major. Baricitinib and Tisagenlecleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Baricitinib may impair CAR T-cell expansion and activity, possibly reducing efficacy. It also adds to the infection risk that follows lymphodepletion and CAR T therapy.
How serious is the interaction between Baricitinib and Tisagenlecleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid baricitinib around leukapheresis and CAR T infusion unless clearly needed. Coordinate with the oncology team and monitor for infection.
What other medicines interact with Baricitinib?
MediHelp also lists interactions of Baricitinib with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Tofacitinib. The full list is on the Baricitinib page.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
